Skip to main content
. Author manuscript; available in PMC: 2014 Sep 11.
Published in final edited form as: Cochrane Database Syst Rev. 2012 Mar 14;3:CD004233. doi: 10.1002/14651858.CD004233.pub3
Methods RCT, DB single oral dose, 3 parallel groups
Medication administered when baseline pain reached a moderate to severe intensity
Pain assessed at 0, 15, 30, 45, 60, 90 mins then hourly up to 12 h, and at 16 and 24 h
Participants Impacted third molar extraction
Mean age 22 years
N = 171
M = 77, F = 94
Interventions Celecoxib 400 mg, n = 57
Ibuprofen 400 mg, n = 57
Placebo, n = 57
Outcomes PI: std 4-point scale
PR: std 5-point scale
Time to use of rescue medication
Number of participants using rescue medication
Number of participants reporting any adverse event and serious adverse events
Number of participants withdrawing due to adverse event
Notes Oxford Quality Score: R2, DB2, W1
Participants asked to refrain from rescue medication for 1 h
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection bias) Low risk “computer-generated randomization schedule, prepared before the start of the study”
Allocation concealment (selection bias) Low risk Medication supplied in patient-specific carton. Identity of assignment contained in concealed section of label, which was removed at dispensing, and attached to patient case report form
Blinding (performance bias and detection bias)
All outcomes
Low risk Double-blind method. Placebo capsules or tablets identical in number and appearance to active treatments
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants accounted for; analysis appropriate for relevant time interval
Other bias Unclear risk Small treatment group size (57 participants)